Skip to main content

carotid artery stenting

Case Report
02/16/2021
Carotid artery stenting—when performed by an experienced operator using an embolic protection device—provides a good alternative for carotid endarterectomy in high-risk patients.
Carotid artery stenting—when performed by an experienced operator using an embolic protection device—provides a good alternative for carotid endarterectomy in high-risk patients.
Carotid artery stenting—when...
02/16/2021
Vascular Disease Management
Taking a Look at the Coming “Radial Revolution”
Editor's Corner
02/16/2021
Dr. Walker comments on Dr. Osama Shoeib and colleagues’ article “Transradial Carotid Artery Stenting Complicated With Neck Hematoma: Conservative is a Valid Option!”
Dr. Walker comments on Dr. Osama Shoeib and colleagues’ article “Transradial Carotid Artery Stenting Complicated With Neck Hematoma: Conservative is a Valid Option!”
Dr. Walker comments on Dr. Osama...
02/16/2021
Vascular Disease Management
New Techniques
10/02/2016
The authors evaluate the performance and effectiveness of micromesh dual-layer technology as a new option for stent-protected angioplasty and to present it as part of the portfolio of carotid artery stents.
The authors evaluate the performance and effectiveness of micromesh dual-layer technology as a new option for stent-protected angioplasty and to present it as part of the portfolio of carotid artery stents.
The authors evaluate the...
10/02/2016
Vascular Disease Management
Case Series
02/06/2012
Abstract carotid artery stenting is the treatment of choice in high-risk patients with extracranial carotid occlusive disease. Bradycardia and hypotension are well-recognized complications of this procedure and are often transient and...
Abstract carotid artery stenting is the treatment of choice in high-risk patients with extracranial carotid occlusive disease. Bradycardia and hypotension are well-recognized complications of this procedure and are often transient and...
Abstract carotid artery stenting...
02/06/2012
Vascular Disease Management
Review
01/06/2012

L. Nelson Hopkins, MD, et al

L. Nelson Hopkins, MD, et al
Methods of cerebral embolic protection during carotid artery stenting focusing on the newest method, proximal occlusion, are discussed in this manuscript.
Methods of cerebral embolic protection during carotid artery stenting focusing on the newest method, proximal occlusion, are discussed in this manuscript.
Methods of cerebral embolic...
01/06/2012
Vascular Disease Management
Case Report
12/02/2011

Hugh B. Milteer, Jr, BA, MBA

Hugh B. Milteer, Jr, BA, MBA
We assessed the risk of intracerebral hemorrhage in patients who underwent carotid artery stenting (CAS) and received glycoprotein IIb/IIIa inhibition as adjunctive antiplatelet therapy.
We assessed the risk of intracerebral hemorrhage in patients who underwent carotid artery stenting (CAS) and received glycoprotein IIb/IIIa inhibition as adjunctive antiplatelet therapy.
We assessed the risk of...
12/02/2011
Vascular Disease Management
Original Research
07/06/2011

Mateen F. Abidi, MD

Mateen F. Abidi, MD
Carotid artery stenting (CAS) is evolving as a less invasive alternative to carotid endarterectomy (CEA) to treat patients with carotid artery stenosis at high surgical risk. However, little is known about the quality and safety of CAS in a...
Carotid artery stenting (CAS) is evolving as a less invasive alternative to carotid endarterectomy (CEA) to treat patients with carotid artery stenosis at high surgical risk. However, little is known about the quality and safety of CAS in a...
Carotid artery stenting (CAS) is...
07/06/2011
Vascular Disease Management
Interview
05/27/2010

Christopher J. White, MD

Christopher J. White, MD
There is now more “texture” to the data, but the conclusion is still that there are no significant differences between the outcomes with carotid artery stenting (CAS) and carotid endarterectomy (CEA). In essence, there were more minor strokes...
There is now more “texture” to the data, but the conclusion is still that there are no significant differences between the outcomes with carotid artery stenting (CAS) and carotid endarterectomy (CEA). In essence, there were more minor strokes...
There is now more “texture” to...
05/27/2010
Vascular Disease Management
Interview
02/02/2010

Interview with Co-Principal Investigators of the ARMOUR Trial: Gary Ansel, MD and L. Nelson Hopkins, MD
 

Interview with Co-Principal Investiga...
Interview with Co-Principal Investigators of the ARMOUR Trial: Gary Ansel, MD and L. Nelson Hopkins, MD
Interview with Co-Principal Investigators of the ARMOUR Trial: Gary Ansel, MD and L. Nelson Hopkins, MD
Interview with Co-Principal...
02/02/2010
Vascular Disease Management
Review
01/07/2010

Daniel J. McCormick, DO

Daniel J. McCormick, DO
Each year about 780,000 people experience a new or recurrent stroke, accounting for 17% of cardiovascular deaths. Approximately 80% of strokes are caused by focal cerebral ischemia and the remaining 20% are caused by hemorrhage.
Each year about 780,000 people experience a new or recurrent stroke, accounting for 17% of cardiovascular deaths. Approximately 80% of strokes are caused by focal cerebral ischemia and the remaining 20% are caused by hemorrhage.
Each year about 780,000 people...
01/07/2010
Vascular Disease Management